Evidence map›Paper›PMID 40647545›Full record

ArticleCancers2025

Tumor Segmentation on PSMA PET/CT Predicts Survival in Biochemical Recurrence of Prostate Cancer: A Retrospective Study Using [

Ken Kudura, Yves Schaulin, Arnoud J Templeton, Tobias Zellweger, Wolfgang Harms, Raphael Georis, Michael C Kreissl, Robert Foerster

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ken KuduraDepartment of Nuclear Medicine, University Hospital CHU UCL Godinne, 5530 Yvoir, Belgium.
Yves SchaulinFaculty of Medicine, University of Basel, 4001 Basel, Switzerland.
Arnoud J TempletonFaculty of Medicine, University of Basel, 4001 Basel, Switzerland.ORCID 0000-0002-0847-7087
Tobias ZellwegerDepartment of Urology, Sankt Clara Hospital, 4058 Basel, Switzerland.
Wolfgang HarmsDepartment of Radiation Oncology, Sankt Clara Hospital, 4058 Basel, Switzerland.
Raphael GeorisDepartment of Biostatistics, University Hospital CHU UCL Godinne, 5530 Yvoir, Belgium.ORCID 0009-0001-3781-5145
Michael C KreisslDivision of Nuclear Medicine, Department of Radiology and Nuclear Medicine, University Hospital Magdeburg, 39120 Magdeburg, Germany.ORCID 0000-0001-5905-6015
Robert FoersterDepartment of Radiation Oncology, Cantonal Hospital Winterthur, 8400 Winterthur, Switzerland.ORCID 0000-0002-7664-9207

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

[18F]-PSMA-1007[68Ga]Ga-PSMA-11biochemical recurrenceoutcome predictionPET/CTprostate cancertumor segmentation

Identifiers

PMID40647545
PMCPMC12249072

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.